Bacoban® Hospital Study from Turkey

As we only got aware of these days the „Biomedical Journal of Scientific & Technical Research“ published the research article „Preventing Spread of Vancomycin-Resistant Enterococci in a Hospital by Using a Nanotechnology-Based Disinfectant“ in December 2018 about a joint study of Istanbul Training and Research Hospital, Gümüshane University, Cerrahpasa Medical Faculty of Istanbul Universityand Faculty of Medicine of Istanbul Medeniyet University.

The study examines the efficacy of Bacoban® in preventing the spread of Vancomycin-resistant Enterococci in a 1,300 bed teaching Hospital in Istanbul. This pathogen causes death, significant illness and localised infections in hospitals throughout the world.

"This study showed that using of Bacoban® remarkably reduced the VRE contamination, compared with levels of VRE contamination detected during the use of sodium hypochlorite (bleach) for disinfection in the control units. These findings have important implications to prevent VRE in endemic health care settings."

The Istanbul study confirms long lasting efficacy for up to 22 days on tile surfaces. It is also important to note that Bacoban® was used to coat medical devices such as "anesthetic devices".

"..colleagues were compared ( sic) the Bacoban® with another disinfectant and found that a single Bacoban® application was equivalent in efficacy to the daily application of the other liquid for 15 days in anesthesia devices in the operating room."

It is important to note that this study is limited to evaluating the efficacy of Bacoban® against a specific pathogen. Additional studies, conducted in a range of environments consistently confirm that Bacoban® provides long lasting efficacy against a wide range of bacteria, viruses and fungi.